Short implants often have the disadvantage of reduced primary stability. The present study was conducted to evaluate the feasibility and safety of a new expandable short dental implant system intended to increase primary stability. As a “proof of concept”, a prospective clinical cohort study was designed to investigate intraoperative handling, primary and secondary implant stability (resonance frequency analysis), crestal bone changes, implant survival and implant success, of an innovative short expandable screw implant. From 2014 until 2015, 9 patients (7–9-mm vertical bone height) with 30 implants (length 5–7 mm, diameter 3.75–4.1 mm) were recruited consecutively. All 30 implants in the 9 patients (age 44 to 80 years) could be inserted and expanded without intraoperative problems. Over the 3-year follow-up period, the implant success rate was 28/30 (93.3%). The mean implant stability quotients (ISQ) were as follows: primary stability, 69.7 ± 10.3 ISQ units, and secondary stability, 69.8 ± 10.2 ISQ units (p = 0.780), both without significant differences between the maxilla and mandible (p ≥ 0.780). The mean crestal bone changes after loading were (each measured from the baseline) as follows: in the first year, 1.0 ± 0.9 mm in the maxilla and 0.7 ± 0.4 mm in the mandible, and in the second year, 1.3 ± 0.8 mm and 1.0 ± 0.7 mm, respectively. Compared to other prospective studies, in this indication, the success rate is acceptable. Implant stability shows high initial and secondary stability values. The system might present an extension of functional rehabilitation to the group of elderly patients with limited vertical bone height. Further long-term investigations should directly compare this compressive implant with standard short implants.

Background and Objectives: Oral health-related quality of life (OHRQOL) is compromised during the post-implant healing period, especially when vertical augmentation is required. A long-term trial sought to evaluate a short dental implant system with an apically expandable macro-design. Materials and Methods: Over 4.5 years, patients with limited vertical alveolar bone were consecutively recruited into this prospective cohort study. Implant success rate, OHRQOL (Oral Health Impact Profile (OHIP)-14), implant stability, and crestal bone changes were evaluated. Results: Data from 30 patients (mean age: 64.6 years, range 44–83) were analyzed, which related to 104 implants (53 in the maxilla, 51 in the mandible). Over the mean follow-up (42.6 ± 16.4 months), the implant success rate was 94.7% in the mandible (two implants lost) and 83.6% in the maxilla (four implants lost; p = 0.096), and the prosthetic success rate was 100%. The median OHIP-14 scores improved from 23 (interquartile range (IQR) 9–25.5) to 2 (IQR 0–5; p < 0.001). The mean implant stability quotient (ISQ) was 71.2 ± 10.6 for primary stability and 73.7 ± 13.3 (p = 0.213) for secondary stability, without significant maxilla-versus-mandible differences (p ≥ 0.066). Compared to the baseline, median crestal bone changes after loading were 1.0 mm (IQR 0–1.3) and 1.0 mm (IQR 0.2–1.2) in the maxilla and mandible (p = 0.508), respectively, at the end of the first year, 1.1 mm (IQR 0–1.3) and 1.0 mm (IQR 0.1–1.2) (p = 0.382), respectively, at the end of the second year, and 1.2 mm (IQR 0–1.9) and 1.1 mm (IQR 0.1–1.2) (p = 0.304), respectively, at the end of the third year. Conclusions: In patients with limited vertical bone height, short implants with optimized macro-design constitute a reliable method for functional rehabilitation, avoiding extensive alveolar bone augmentation.